ArticleBMC health services research2023

Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.

Eugenia Oviedo-Joekes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.